ea0098t12 | Trials In Progress | NANETS2023
Mailman Josh
, Ralic Danielle
, del Rivero MD Jaydira
, Gericke MD Germo
, Halfdanarson MD Thorvardur R.
, Herrmann MD Ken
, Hollander Ronald
, Albert Fisher Jr. MD George
Background: Finding relevant neuroendocrine tumor (NET) trials remains a challenge for patients and healthcare professionals (HCPs). Clinicaltrials.govs taxonomy associates many conditions with NETs, complicating the discovery process. As of 6/30/23 clinicaltrials.gov listed 700 recruiting, phase 1-3 interventional trials using the terms Neuroendocrine Tumors, Pheochromocytoma, and Paraganglioma. Many of these trials are not relevant for patients with NETs. Even with sev...